|本期目录/Table of Contents|

[1]杨 敏,谢集建,陈 炜.十堰地区婴幼儿社区获得性肺炎常见病原体致病情况及耐药性变迁分析[J].中华肺部疾病杂志,2020,(06):737-741.[doi:10.3877/cma.j.issn.1674-6902.2020.06.004]
　Yang Min,Xie Jijian,Chen Wei..Pathogenicity and drug resistance changes of common pathogens of infant community acquired pneumonia in Shiyan area[J].,2020,(06):737-741.[doi:10.3877/cma.j.issn.1674-6902.2020.06.004]
点击复制

十堰地区婴幼儿社区获得性肺炎常见病原体致病情况及耐药性变迁分析(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2020年06期
页码:
737-741
栏目:
论著
出版日期:
2020-12-20

文章信息/Info

Title:
Pathogenicity and drug resistance changes of common pathogens of infant community acquired pneumonia in Shiyan area
作者:
杨 敏1; 谢集建1; 陈 炜2
442000 湖北省十堰市太和医院儿童医疗中心二病区1 442000 湖北省十堰市太和医院检验科2
Author(s):
Yang Min1;  Xie Jijian1;  Chen Wei2.
1Ward Two, Children's Medical Center, Taihe Hospital, Shiyan City, Shiyan 442000 China; 2Clinical Laboratory, Taihe Hospital, Shiyan City, Shiyan 442000, China
关键词:
婴幼儿;  社区获得性肺炎;  病原体;  耐药性
Keywords:
Infants;  Community acquired pneumonia;  Pathogens;  Drug resistance
分类号:
-
DOI:
10.3877/cma.j.issn.1674-6902.2020.06.004
摘要:
目的 分析十堰地区婴幼儿社区获得性肺炎(CAP)常见病原体致病情况及耐药性的变迁。方法 选取2018年2月至2019年2月十堰区多家医院收治的1 282例CAP患儿,采集所有患儿深部痰液标本,对痰液中细菌菌种进行鉴定,采用MIC法进行药敏试验,并分析检出细菌对常用抗菌药物的耐药情况。结果 282例CAP患儿中病原体检出阳性者684例(53.35%),其中肺炎链球菌检出146例(21.35%),肺炎链球菌、大肠埃希菌、金黄色葡萄球菌、铜绿假单胞菌、产气肠杆菌、阴沟肠杆菌在年龄≤12个月的患儿中检出率明显高于年龄12～36个月的患儿(均P<0.05)。1 282例患儿肺炎支原体检出率为6.16%(79/1282),肺炎衣原体检出率为11.39%(146/1 282),肺炎支原体/衣原体在年龄12～36个月的患儿中检出率分别为13.71%(51/372)、25.81%(96/372)明显高于年龄≤12个月患儿的3.08%(28/910)、5.49%(50/910)(P<0.05)。在革兰氏阳性菌中,肺炎链球菌对红霉素、四环素、克林霉素耐药率均>80%,金黄色葡萄球菌对青霉素、红霉素、克林霉素、氨苄西林耐药率均>50%; 肺炎链球菌和金黄色葡萄球菌对万古霉素、利奈唑胺均敏感。在革兰氏阴性菌中,大肠埃希菌和肺炎克雷伯菌均对头孢唑林、头孢他啶、头孢吡肟、头孢曲松、氨苄西林、氨曲南耐药率>70%; 流感嗜血杆菌对氨苄西林耐药率最高; 铜绿假单胞菌对头孢曲松、头孢替坦均100%耐药; 革兰氏阳性菌对哌拉西林及阿米卡星耐药率最低。结论 十堰地区婴幼儿社区获得性肺炎常见病原体为肺炎链球菌,主要对红霉素、四环素、克林霉素耐药率均较高,临床应当使用敏感抗菌素提高治疗效率。
Abstract:
Objective To analyze the pathogenicity and drug resistance changes of common pathogens of infant community acquired pneumonia in Shiyan area. Methods 1 282 children with cap admitted to many hospitals in Shiyan district from February 2018 to February 2019 were selected to collect the deep sputum samples of all children, identify the bacterial species in the sputum, carry out the drug sensitivity test with MIC method, and detect the resistance of the bacteria detected to the commonly used antibiotics. Results in 282 children with cap, 684(53.35%)were positive in physical examination, of which 146(21.35%)were positive in Streptococcus pneumoniae, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Enterobacter aerogenes and Enterobacter cloacae(P<0.05). The detection rates of Mycoplasma pneumoniae and Chlamydia pneumoniae were 6.16%(79/1 282)and 11.39%(146/1 282), respectively. The detection rates of Mycoplasma pneumoniae and Chlamydia pneumoniae in children aged 12-36 months were 13.71%(51/372)and 25.81%(96/372), respectively, which were significantly higher than 3.08%(28/910)and 5.49%(50/910)of children with age ≤12 months(all P<0.05). Among Gram-positive bacteria, the resistance rate of Streptococcus pneumoniae to erythromycin, tetracycline and clindamycin was more than 80%, that of Staphylococcus aureus to penicillin, erythromycin, clindamycin and ampicillin was more than 50%, and that of Streptococcus pneumoniae and Staphylococcus aureus to vancomycin and linezolid. Among Gram-negative bacteria, Escherichia coli and Klebsiella pneumoniae were resistant to cefazolin, ceftazidime, cefepime, ceftriaxone, ampicillin, and aztreonam more than 70%; Haemophilus influenzae was resistant to ampicillin the highest; Pseudomonas aeruginosa was resistant to ceftriaxone and cefotetan 100%; Gram-positive bacteria were resistant to piperacillin and amikacin the lowest. Conclusion Streptococcus pneumoniae is the common pathogen of infant community acquired pneumonia in Shiyan area, which is resistant to erythromycin, tetracycline and clindamycin. Sensitive antibiotics should be used to improve the treatment efficiency.

参考文献/References:

1 Pieralli F, Vannucchi V, Marzi GD, et al. Performance status and in-hospital mortality of elderly patients with community acquired pneumonia[J]. Internal & Emergency Medicine, 2018, 13(2): 1-7.
2 黄展智, 韦 益, 唐春兰, 等. 312例儿童社区获得性肺炎病原体分布及耐药性分析[J]. 广西医科大学学报, 2019, 36(9): 1514-1517.
3 Ito A, Ishida T, Tachibana H, et al. Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumonia[J]. Clin Chem Lab Med, 2019, 57(10): 1632-1637.
4 徐 娟, 殷 勇, 赵丽霞, 等. 上海儿童社区获得性肺炎致病菌分布及耐药性分析[J]. 中华实用儿科临床杂志, 2018, 33(16): 1246-1250.
5 Rijkers GT, Holzer L, Dusselier T. Genetics in community-acquired pneumonia[J]. Current Opinion in Pulmonary Medicine, 2019, 25(3): 323-329.
6 Para RA, Fomda BA, Jan RA, et al. Microbial etiology in hospitalized North Indian adults with community-acquired pneumonia[J]. Lung India, 2018, 35(2): 108-115.
7 覃理平. 小儿社区获得性肺炎的致病菌分布及耐药性分析[J]. 中国社区医师, 2019, 035(005): 17, 20.
8 罗艳星. 75例社区获得性肺炎患儿呼吸道深处痰液标本中致病菌的分布及其对抗菌药物的耐药性分析[J]. 抗感染药学, 2020, 91(2): 76-78.
9 Yukiyo S, Yasuhiro Y, Hideo Y, et al. Guidelines-concordant empiric antimicrobial therapy and mortality in patients with severe community-acquired pneumonia requiring mechanical ventilation[J]. Respir Invest, 2017, 55(1): 39-44.
10 Wiersinga WJ, Bonten MJ, Boersma WG, et al. Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy(SWAB)and Dutch Association of Chest Physicians(NVALT)[J]. Netherlands J Med, 2018, 76(1): 4-13.
11 Kolditz M, Ewig S. Community-Acquired Pneumonia in Adults[J]. Deutsches Rzteblatt International, 2017, 114(49): 838-848.
12 中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会. 儿童社区获得性肺炎管理指南(2013修订)(上)[J]. 中华儿科杂志, 2013, 51(10): 745-752.
13 Goji H, Shimomura M, Uemura Y, et al. Abstract 329: Establishment of three-dimensional primary tumor cell culture method and novel drug sensitivity test[J]. Cancer Res, 2015, 75(15 Supplement): 329-329.
14 沙文光, 戴本启, 叶发展. 儿童重症社区获得性肺炎病原体分布及细菌耐药情况分析[J]. 承德医学院学报, 2019, 36(1): 28-31.
15 Soudack M, Plotkin S, Ben-Shlush A, et al. The Added Value of the Lateral Chest Radiograph for Diagnosing Community Acquired Pneumonia in the Pediatric Emergency Department[J]. Israel Medical Association Journal Imaj, 2018, 1(20): 5-8.
16 Grèce Saba, Andrade LF, Gaillat J, et al. Costs associated with community acquired pneumonia in France[J]. Eur J Health Economics, 2017, 19(11): 1-12.
17 李雅杰, 张全新, 李 锋, 等. 唐山市区社区获得性肺炎患儿病原体分布及其耐药性分析[J]. 检验医学与临床, 2018, 15(9): 1278-1280.
18 董九龙, 徐新娟, 徐 建, 等. 宜昌市住院儿童难治性社区获得性肺炎的病原体及临床特征分析[J]. 临床肺科杂志, 2018, 23(9): 117-121.
19 廖克准, 韦海林, 韦海深, 等. 儿童社区获得性肺炎病原体分布与临床用药分析[J]. 临床医药文献电子杂志, 2019, 6(10): 3-5.
20 Posten S, Reed J. Pediatric Community Acquired Pneumonia[J]. South Dakota J Med, 2017, 70(12): 557-561.
21 Leong CL, Ahmad N, Azmel A, et al. Community-acquired necrotising pneumonia caused by panton-valentine leucocidin-producing methicillin-resistant staphylococcus aureus[J]. Med J Malaysia, 2017, 72(6): 378-379.
22 Korkmaz MF, Ahmet Güzel, Mehmet Açkgöz, et al. Reliability of Pro-adrenomedullin and Interleukin 1β in Predicting Severity of Community-Acquired Pneumonia in Pediatric Patients[J]. Annals of Clinical & Laboratory Science, 2018, 48(1): 81-89.
23 冯 雪, 田庆玲, 张 双, 等. 儿童社区获得性肺炎病原体分析及对患儿T细胞水平的影响[J]. 中国免疫学杂志, 2019, 35(3): 104-109.
24 Kumar KJ, Chowdary KVA, Usha HC, et al. Etiology of community acquired pneumonia among children in India with special reference to atypical pathogens[J]. Lung India, 2018, 35(2): 116-120.
25 郭文卉, 曹 玲. 儿童社区获得性肺炎病原体分布特点分析[J]. 中国医刊, 2019, 054(003): 310-314.
26 刘 娟, 尚 彪, 白 静, 等. 749例社区获得性肺炎儿童的病原体分布特点[J]. 西部医学, 2019, 31(05): 81-86.
27 马 权, 李树民, 赵艳景, 等. 我院社区获得性肺炎革兰氏阴性杆菌感染情况和细菌耐药变迁的研究[J]. 齐齐哈尔医学院学报, 2017, 5(24): 41-44.
28 lak ES, Alisik M, Hezer H, et al. Evaluation of dynamic thiol/disulfide redox state in community-acquired pneumonia[J]. Saud Med J, 2018, 39(5): 495-499.
29 刘 庆, 杜 娟. 贵阳地区老年人社区获得性肺炎的病原学分析[J]. 贵阳医学院学报, 2016, 41(2): 216-218.
30 徐青青, 彭春燕, 苏庸春, 等. 儿童社区获得性肺炎病原菌及耐药性的变迁[J]. 儿科药学杂志, 2020, 26(6): 49-51.
31 张 利, 李劲松, 段宝珍. 临床征象对儿童社区获得性肺炎支原体肺炎的鉴别价值[J/CD]. 中华肺部疾病杂志(电子版), 2017, 10(6): 725-727.
32 Temel MT, Demiryürek S, Temel L, et al. Dynamic thiol/disulfide homeostasis in children with community-acquired pneumonia[J]. Pediatr Int, 2019, 61(3): 252-257.

备注/Memo

备注/Memo:
基金项目: 国家自然科学基金资助项目(81402508)
通信作者: 谢集建, Email: 2264295730@qq.com
更新日期/Last Update: 2020-12-20